authorandyear,gmfcs,wppsi_iii,wisc_iv,bayley_ii_cognitive,bayley_iii_cognitive,bayley_iii_language,bayley_ii_cognitive_p_value,bayley_iii_cognitive_p_value,bayley_iii_language_p_value,definition,time_window,significance,geographic_origin,treatment,sample_size
Ambalavanan et al. 2006,"level 3-5 indicates severe disability, level 2 indicates moderate disability",,,70.0,-1.0,-1.0,-1.0,-1.0,-1.0,Death or moderate/severe disability at 18 to 22 months.,18 to 22 months after birth.,"Correct classification rates for death/disability were 78% for scoring systems, 80% for classification and regression tree models, and 67% with severe encephalopathy in early neurologic examination.",USA,Hypothermia,205.0
"Ambalavanan et al., 2006",Gross motor function was graded according to the GMFCS with levels from 1 to 5.,,,-1.0,-1.0,-1.0,-1.0,-1.0,-1.0,"Death or moderate/severe disability assessed by mental development index score, GMFCS grade, hearing or vision impairment, or persistent seizure disorder.",18 to 22 months after birth,51% experienced death or disability,United States,Hypothermia,205.0
"Laptook et al., 2009","Level 3 to 5 indicates severe disability, Level 2 indicates moderate disability.",,,70.0,-1.0,-1.0,-1.0,-1.0,-1.0,Death or moderate/severe disability at 18 to 22 months of age.,18 to 22 months of age.,Each point decrease in Apgar score at 10 minutes was associated with a 45% increase in the odds of death or disability.,United States,Whole-body hypothermia,208.0
"Natarajan G, et al. 2013","The GMFCS was used to categorize the severity of CP (levels I-V), with severe disability being level IV or V and moderate disability being level III","The WPPSI-III for children below 7 years and 3 months was used to evaluate verbal, performance, and full scale IQ","For older children, the WISC-IV was used for evaluation",-1.0,-1.0,-1.0,-1.0,-1.0,-1.0,Death or moderate/severe disability at 6–7 years of age.,6–7 years,Each point increase in 10 min Apgar scores was associated with a significantly lower risk of death/disability (p<0.05).,USA,Whole body cooling,174.0
Perez JMR et al. Rev Assoc Med Bras 2017,,,,-1.0,-1.0,-1.0,-1.0,-1.0,-1.0,"The study does not specify a single primary outcome but focuses on the development and validation of a simple clinical neurological score for the early diagnosis and management of hypoxic-ischemic encephalopathy (HIE) in newborns, which involves assessing ten clinical aspects for diagnosis and management guidance.","The score is to be used from the delivery room onwards, beginning as soon as the Apgar score is completed and for continuous evaluation over the first hours and days of life.","The study aims to facilitate early diagnosis and appropriate therapeutic measures, such as therapeutic hypothermia, by using a simple, easily implemented clinical score from the Iberoamerican Society of Neonatology (Siben) to improve outcomes for newborns with hypoxic-ischemic encephalopathy, especially in resource-limited settings.",Brazil,Therapeutic hypothermia,26.0
Perez JMR et al. 2017,N/A,N/A,N/A,-1.0,-1.0,-1.0,-1.0,-1.0,-1.0,"The primary outcome of the study is a simple clinical neurological score for hypoxic-ischemic encephalopathy developed by the Iberoamerican Society of Neonatology (Siben), which is used to assess and categorize the severity of hypoxic-ischemic encephalopathy in newborns as mild, moderate, or severe based on clinical symptoms.","The neurological score is intended to be used from the first minutes of life onwards, starting immediately after the Apgar score is completed in the delivery room.","The score assists in the early diagnosis and management of hypoxic-ischemic encephalopathy, potentially improving treatment outcomes by facilitating timely therapeutic interventions such as therapeutic hypothermia.","São Paulo, SP, Brazil",A new clinical diagnostic score for infants with asphyxia,26.0
